Kikora is one of Norway's leading digital edtech companies. We provide an e-learning platform for mathematics. Our unique maths engine and technology platform contributes to better learning among several hundred thousand Norwegian students. We consider ourselves one of the best places in edtech to work. Over half of Norway's students use Kikora, and we are growing.

Agens has an award-winning team in the field of concept work, design and mobile development. We work hard to make sure your brand comes alive in the right digital channels – wrapped in a refreshing, world-class user experience.    At Agens, we have conceptualized, designed and developed some of the biggest mobile software projects in Scandinavia ever since Steve Jobs pulled the iPhone out of his turtleneck.

Working Group Two enables product development and differentiation for telecom operators. It does this with public APIs and an app ecosystem on its cloud-native core network. It also collaborates with companies such as AWS, Atos and CCA to offer operators a simplified, end-to-end mobile network solution. If you love product development, green field projects, cloud computing, edge and Open RAN technologies, Working Group Two is for you!

We are streamlining the process of tax free shopping for travellers, maximizing value and efficiency for both travellers and retailers alike. With our fully digitized end-to-end solution, retailers can facilitate, and travellers can claim VAT refunds at the touch of a button on their mobile device. Our team consists of Silicon Valley entrepreneurs, experienced leaders and talented people. Come join us!

Startup accelerator, investor, and ecosystem builder based in Trondheim, Norway! See more on LinkedIn: linkedin.com/company/6am-accelerator Accelerator: We host a 6-month accelerator program for pre-seed tech startups focused on business development, such as fundraising, sales, marketing, and legal. 35+ startups have attended since 2021. Investments: We facilitate a pre-seed investment fund called Gnist Capital, where we invest up to 1 MNOK. Ecosystem building: StartupTRD is a project aiming to increase the attractiveness of the Trondheim startup scene, including regular events, co-working, corporate innovation, and more. Check out startuptrd.no.

Short Description: Mindbuddy is developing an AI-powered mental training app to help young athletes build confidence, focus, and resilience by combining sports psychology with accessible, easy-to-use tools designed for their daily routines. The What: Mental training is often inaccessible to young athletes due to stigma, cost, or limited resources at clubs. This leaves players struggling with performance anxiety, self-doubt, and inconsistent focus - issues that directly impact their performance and well-being. Despite its importance, mental training remains underutilized, especially in grassroots and academy-level sports. With over 50% of players reporting struggles with confidence and performance pressure, this is a problem that affects millions of young athletes worldwide. The How: Mindbuddy bridges the gap between mental training and accessibility by delivering tailored sports psychology tools directly to players’ phones. Using AI, the app helps players set SMART goals, generate visualization tracks, and build mental routines for training and matches. For clubs, Mindbuddy offers a simple platform to track team well-being, measure progress, and provide coaches with actionable insights - allowing mental training to seamlessly integrate into the day-to-day routines of both players and teams. The Why: As a professional footballer for 18 years, including many as captain of Vålerenga, I’ve experienced firsthand the enormous pressure players face. It wasn’t until the latter part of my career, when I discovered the power of mental training, that I realized how much better prepared and focused I could be. That sparked the idea for Mindbuddy. I wanted to create a tool that made mental training accessible to every young athlete, breaking down the barriers of stigma and cost, and ensuring they can unlock their full potential - both on and off the pitch.

Aker-owned industrial scale-up seeking to industrialize and digitize the operations and maintenance (O&M) in the energy sector. Out business model is based on being the orchestrator in the value chain and reduce sub-optimal decision making and value-leakage during the project phase. Føn has offices in Oslo, Stavanger, Sweden and Denmark and soon also UK.

Stack by.me is a social media platform where users can invest together, making investments more engaging and available to non-professionals - especially women. Today, there is a substantial capital gap in Norway and globally. In Norway, the gap is as large as a Norwegian state budget. (which is huge!) - only 20% of the value of Oslo Børs is owned by women today - Women invest 63% less than men, on average - while we only make 11% less - At the same time, 86% of all min. pension receivers are women, so women should be investing more - not less! Why is that? Women tell us - they don´t feel like they have enough knowledge - they don´t know who to ask for help Through the Stack-app, we give them the network to learn from and discuss investments - in an easy and fun way.

Oivi is preventing blindness among diabetes patients by deploying an AI camera for the automated diagnosis of retinal diseases. We are an ambitious and young medtech company developing a technology to overcome a huge challenge that impacts the lives of millions of people with diabetes. Our vision is to bring to market a low-cost artificial intelligence-enabled retinal camera and automated diagnostics platform for the early screening of Diabetic Retinopathy. We are an experienced team based in Norway and India, trying to achieve what nobody has done so far and we are trying to get there with high speed. Want to join us?

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

Lime Go - a fast growing SaaS 'startup' without any financial or personal risk for you. Wait, what - how?🤔 We are an autonomous business unit within the Lime Technologies Group, giving us the awesome perks of being a Nasdaq-listed company as well as the freedom of a startup. Lime Technologies was founded in 1990 and is the market leader in the Nordics when it comes to CRM. We've had different CRM-products in our portfolio over the years and now it's time to let Lime Go, go big. 🚀 What is the story behind Lime Go?🍑 Lime Go is the ONLY CRM tool for sales and marketing departments with integrated company data. It is excellent for prospecting and filled with valuable company data to help users save time and increase revenue. We help users with their daily work through insights and educate them to be more proactive, providing an ROI from day 1. During 2021 we finished a product redesign to up our game in regard to tech stack, UI, modernity and power. We're now ready to step on the gas pedal and conquer Europe! Who are Lime Technologies and what is Lime Go?🍈 Publicly listed Lime Technologies have a turnover of approx. €40M with 400 employees in 7 countries, divided in 10 offices. We have a local presence in Sweden, Norway, Denmark, Finland, Netherlands, Germany and Poland. Lime Go is part of it and we're a team of 12 people running our own startup unit! The upcoming years will be full speed ahead to recruit and build a team to scale the product for our launch in Europe. Currently we have a strong market position in Sweden with recently launched campaigns in Norway & Denmark - but we have higher ambitions. We will become the most intuitive and user-friendly CRM system in all of Europe and be the obvious choice for ambitious companies. 🌍 Don't hesitate to apply for our open positions and join our team - as we embark on this unique journey!🎢

Iris.ai is on a mission to build the world's first AI researcher, a system that will be an invaluable team member in every research team across academia, industry and NGO's. We are an impact driven for-profit company. Our initial product offering is a suite of tools to semi-automate the academic literature reviews, and these tools are being delivered at University Libraries across the Nordics. Our second product suite is a set of tools for researchers in the chemical industry. Our team is a mishmash of impact driven weirdos with a fundamental desire to do really cool things that will leave the world better than we found it.

Vi hjelper eiendomsutviklere med å skape drømmehjem!BYGR er et kommunikasjonsverktøy som forenkler dialogen mellom kjøper og selger av bolig. BYGR setter kjøperen i sentrum, og gjør prosessen med å skape drømmehjemmet til en god opplevelse.Bygr forbinder selgere, kjøpere og entreprenører! Hvis du har spørsmål eller ønsker å vite mer, ta kontakt med oss!

We've grappled with the complexities of managing SaaS subscriptions in past roles, and we believe it doesn't have to be this hard. Traditional solutions in the market often felt elusive and burdened with top-down procedures, offering little joy to the end-user. This sparked the idea for Cardboard. Our goal is simple: take away these headaches and make SaaS management straightforward and even enjoyable. Rooted in a love for simplicity and a good user experience, Cardboard aims to make your life easier. From Norway to the world, we're excited to redefine how businesses interact with software subscriptions one company at a time.

Age Labs is a Norwegian molecular diagnostics company that discovers, develops and commercializes biomarkers for the early detection of age-related diseases. We offer a service for evaluating epigenetic drug effects for use in clinical trials. Our biomarker discovery pipeline includes a biological age predictor and a test predicting the severity of COVID-19 infection. To date, we have raised 30 MNOK in private and public funding, and became a Nordic Startup Awards finalist in 2020. We are supported by strong commercial and R&D partners, including Oslo University Hospital, the Norwegian Institute of Public Health, Merck Group and Fürst Medical Laboratory. Our mission is to develop novel precision biomarkers for the early detection of age related diseases to extend the human healthspan.